Literature DB >> 23242002

Breast dynamic contrast-enhanced examinations with fat suppression: are contrast-agent uptake curves affected by magnetic field inhomogeneity?

Maria A Schmidt1, M Borri, E Scurr, G Ertas, G Payne, E O'Flynn, N Desouza, M O Leach.   

Abstract

OBJECTIVES: To investigate the effect of magnetic field heterogeneity in breast dynamic contrast-enhanced examinations with fat saturation (DCE-FS).
METHODS: The magnetic field was mapped over the breasts in ten patients. DCE-FS was undertaken at 1.5 T with fast spoiled gradient echoes and spectrally selective fat saturation. Signal intensity was calculated for T1 values 25-1,200 ms both on and off resonance, and results were verified with a test object. Clinical examinations were evaluated for the predicted effects of field heterogeneity.
RESULTS: Magnetic field was found to vary by 3.6 ± 1.2 ppm over the central transaxial slice and 5.1 ± 1.5 over the whole breast volume (mean ± standard deviation). Computer simulations predict a reduction in the dynamic range if field heterogeneity leads to unintended water suppression, and distortion to CA uptake curves due to fat suppression failure (for fat containing pixels). A compromise between dynamic range and fat saturation performance is required. Both water suppression and fat suppression failure are apparent in clinical examinations.
CONCLUSION: Magnetic field heterogeneity is likely to reduce the sensitivity of DCE-FS by distorting the CA uptake curves because of fat suppression failure (for fat containing pixels) and by reducing the dynamic range because of unintended water suppression. KEY POINTS: • Magnetic field heterogeneity is significant in breast magnetic resonance. • Contrast-agent uptake curves are distorted by a non-uniform magnetic field. • Radiologist must be aware of possibility of distortion to interpret uptake curves correctly. • Compromise between fat suppression and dynamic range is required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242002     DOI: 10.1007/s00330-012-2735-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL.

Authors:  Rebecca Rakow-Penner; Bruce Daniel; Huanzhou Yu; Anne Sawyer-Glover; Gary H Glover
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

2.  The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.

Authors:  P Di Giovanni; C A Azlan; T S Ahearn; S I Semple; F J Gilbert; T W Redpath
Journal:  Phys Med Biol       Date:  2010-01-07       Impact factor: 3.609

3.  Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.

Authors:  Matthias C Schabel; Dennis L Parker
Journal:  Phys Med Biol       Date:  2008-04-17       Impact factor: 3.609

4.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

Authors:  Christiane K Kuhl; Simone Schrading; Claudia C Leutner; Nuschin Morakkabati-Spitz; Eva Wardelmann; Rolf Fimmers; Walther Kuhn; Hans H Schild
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

5.  Snapshot FLASH MRI. Applications to T1, T2, and chemical-shift imaging.

Authors:  A Haase
Journal:  Magn Reson Med       Date:  1990-01       Impact factor: 4.668

6.  Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.

Authors:  Huong T Le-Petross; Gary J Whitman; Deanne P Atchley; Ying Yuan; Angelica Gutierrez-Barrera; Gabriel N Hortobagyi; Jennifer K Litton; Banu K Arun
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

7.  Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.

Authors:  Ellen Warner; Petrina A Causer; John W-N Wong; Frances C Wright; Roberta A Jong; Kimberley A Hill; Sandra J Messner; Martin J Yaffe; Steven A Narod; Donald B Plewes
Journal:  Breast J       Date:  2011 Jan-Feb       Impact factor: 2.431

Review 8.  Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?

Authors:  C Kuhl; W Kuhn; M Braun; H Schild
Journal:  Breast       Date:  2007-10-23       Impact factor: 4.380

9.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

10.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Authors:  Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  3 in total

1.  Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.

Authors:  Akiko Shimauchi; Hiroyuki Abe; David V Schacht; Jian Yulei; Federico D Pineda; Sanaz A Jansen; Rajiv Ganesh; Gillian M Newstead
Journal:  Eur Radiol       Date:  2015-02-20       Impact factor: 5.315

2.  Quantitative evaluation of contrast agent uptake in standard fat-suppressed dynamic contrast-enhanced MRI examinations of the breast.

Authors:  Evanthia Kousi; Joely Smith; Araminta E Ledger; Erica Scurr; Steven Allen; Robin M Wilson; Elizabeth O'Flynn; Romney J E Pope; Martin O Leach; Maria A Schmidt
Journal:  Med Phys       Date:  2017-11-30       Impact factor: 4.071

3.  Investigating the influence of flip angle and k-space sampling on dynamic contrast-enhanced MRI breast examinations.

Authors:  Araminta E W Ledger; Marco Borri; Romney J E Pope; Erica D Scurr; Toni Wallace; Cheryl Richardson; Marianne Usher; Steven Allen; Robin M Wilson; Karen Thomas; Nandita M deSouza; Martin O Leach; Maria A Schmidt
Journal:  Acad Radiol       Date:  2014-08-30       Impact factor: 3.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.